Research, News & Discoveries

This year’s Excellence in Undergraduate Research Mentoring Award was awarded to Carrie Jones, associate professor of pharmacology, for her work understanding schizophrenia, Alzheimer’s disease and addiction and her willingness to support students in her lab. Read More

The 2024 Center for Structural Biology Symposium, which took place on March 28, celebrated its decades of success, research undertakings, and goal of strengthening the structural biology community at Vanderbilt. Read More

Jennifer Pietenpol, Executive Vice President for Research and chief scientific and strategy officer for VUMC and professor of biochemistry and otolaryngology, is the 2024 recipient of the Science of Oncology Award, for outstanding contributions to basic or translational research in cancer. She is among a select group of global oncology leaders being recognized with special awards by ASCO and Conquer Cancer, the organization’s foundation. Read More

Fourteen biomedical sciences students from across the School of Medicine Basic Sciences and the School of Medicine have been awarded the Provost Pathbreaking Discovery Award from the Graduate School. Read More

Congratulations to our School of Medicine Basic Sciences community members who were promoted or received new appointments from January to March 2024! These individuals significantly enrich our pursuit of pathbreaking research and contribute to the growth and success of our school. Read More

Antentor Hinton Jr. spearheaded a collaboration with labs from across Vanderbilt University, the U.S., and Brazil to create 3D maps of mitochondria inside brown adipose tissue, which may help researchers identify potential therapies to treat metabolic ailments. Read More

Walter Chazin, Chancellor’s Chair in Medicine and professor of biochemistry and chemistry, has been named senior associate dean of biomedical research education and training. Kathleen Gould, Louise B. McGavock Chair, is stepping down from the role after 14 years with the BRET Office to return her focus to her research program in the department of cell and developmental biology. Read More

Davies received a Scaling Success grant to advance research on NAPE-PLD activators—potential key players in fighting cardiometabolic diseases. The team’s innovative research could lead to breakthrough treatments. Read More

Leading investigators in diabetes, pancreas and islet biology, and computational biology have received $12.5 million in two five-year awards from the National Institutes of Health to create the world’s first, integrated knowledge base of human-derived tissue- and cellular-level pancreatic information to support innovative, collaborative and reproducible research. Read More

Led by Neil Osheroff, Vanderbilt researchers are the first to undertake a systematic analysis of the mechanism of action of geoptidacin. Gepotidacin is poised to become the first new class of antibacterials to be approved for use in humans in decades. Read More